FIG A2.

(A) Disease-free survival and (B) overall survival of patients with fewer than 44 chromosomes who received chemotherapy only or underwent hematopoietic cell transplantation. Curves originate at a landmark of 153 days (median time from complete remission to transplantation) to adjust for bias related to early events and account for delayed entry of patients into the transplantation group. The first set of No. at risk is at 0.42 years (153 days) since complete remission for both panels A and B.